Beone Medicines Ltd
(ONC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 220,431 | 95,590 | 1,270 | -644,786 | -492,905 |
| Depreciation Amortization | 105,702 | 68,418 | 32,804 | 171,762 | 121,516 |
| Income taxes - deferred | N/A | N/A | N/A | 25,983 | N/A |
| Accounts receivable | -167,294 | -73,369 | -31,866 | -329,443 | -203,744 |
| Accounts payable and accrued liabilities | -7,381 | -35,852 | -31,568 | 121,497 | 13,536 |
| Other Working Capital | 27,346 | -72,674 | -78,027 | -157,167 | -138,305 |
| Other Operating Activity | 531,429 | 325,567 | 151,469 | 671,523 | 484,111 |
| Operating Cash Flow | $710,233 | $307,680 | $44,082 | $-140,631 | $-215,791 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,800 | 1,800 | 1,800 | 2,655 | 2,655 |
| PPE Investments | -148,317 | -100,233 | -56,407 | -492,663 | -400,183 |
| Purchase Of Investment | N/A | N/A | N/A | -19,006 | N/A |
| Purchase Sale Intangibles | -20,000 | -20,000 | N/A | -4,674 | -4,674 |
| Other Investing Activity | -91,303 | -90,113 | -67,334 | -39,336 | -57,217 |
| Investing Cash Flow | $-237,820 | $-188,546 | $-121,941 | $-548,350 | $-454,745 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 221,521 | 221,521 | 80,000 | 868,270 | 324,412 |
| Debt Issued | N/A | N/A | N/A | 9,053 | 9,053 |
| Debt Repayment | -21,062 | -16,799 | -4,215 | -28,031 | -17,581 |
| Common Stock Issued | 177,038 | 96,503 | 63,359 | 45,373 | 36,578 |
| Other Financing Activity | 585,023 | -299,977 | -172,921 | -701,216 | -154,490 |
| Financing Cash Flow | $962,520 | $1,248 | $-33,777 | $193,449 | $197,972 |
| Exchange Rate Effect | 36,862 | 26,957 | 3,480 | -51,705 | 8 |
| Beginning Cash Position | 2,638,747 | 2,638,747 | 2,638,747 | 3,185,984 | 3,185,984 |
| End Cash Position | 4,110,542 | 2,786,086 | 2,530,591 | 2,638,747 | 2,713,428 |
| Net Cash Flow | $1,471,795 | $147,339 | $-108,156 | $-547,237 | $-472,556 |
| Free Cash Flow | |||||
| Operating Cash Flow | 710,233 | 307,680 | 44,082 | -140,631 | -215,791 |
| Capital Expenditure | -148,317 | -100,233 | -56,407 | -492,663 | -400,183 |
| Free Cash Flow | 561,916 | 207,447 | -12,325 | -633,294 | -615,974 |